VAREX IMAGING ROE 2015-2019 | VREX

Current and historical return on equity (ROE) values for VAREX IMAGING (VREX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. VAREX IMAGING ROE for the three months ending June 30, 2019 was 10.01%.
VAREX IMAGING ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.01B $0.44B 1.85%
2019-03-31 $0.01B $0.44B 3.03%
2018-12-31 $0.02B $0.43B 4.49%
2018-09-30 $0.03B $0.43B 6.50%
2018-06-30 $0.04B $0.42B 10.42%
2018-03-31 $0.05B $0.41B 12.65%
2017-12-31 $0.05B $0.40B 14.05%
2017-09-30 $0.05B $0.38B 12.71%
2017-06-30 $0.06B $0.36B 13.24%
2017-03-31 $0.07B $0.34B 18.54%
2016-12-31 $0.07B $0.55B 24.44%
2016-09-30 $0.07B $0.53B 52.47%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.115B $0.773B
Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates primarily in North America, Europe and Asia. Varex Imaging Corporation is based in Salt Lake City, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.330B 27.69
Medtronic (MDT) Ireland $146.309B 20.54
Stryker (SYK) United States $80.541B 27.85
Boston Scientific (BSX) United States $58.421B 28.34
Baxter (BAX) United States $44.378B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.384B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.264B 18.09
Lonza Group Ag (LZAGY) Switzerland $24.906B 0.00
Coloplast (CLPBY) Denmark $24.894B 39.74
Terumo (TRUMY) Japan $22.254B 25.59
Smith & Nephew SNATS (SNN) United Kingdom $20.394B 0.00
ResMed (RMD) United States $18.779B 35.81
Sunny Optical Technology (SNPTF) China $16.365B 0.00
Bio-Rad Laboratories (BIO) United States $9.957B 53.38
Canopy Growth (CGC) Canada $9.657B 0.00
Insulet (PODD) United States $8.625B 511.07
Perrigo (PRGO) Ireland $7.714B 14.21
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.923B 20.64
Haemonetics (HAE) United States $6.394B 48.25
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.561B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.233B 0.00
Neogen (NEOG) United States $4.125B 68.48
NuVasive (NUVA) United States $3.402B 27.12
ICU Medical (ICUI) United States $3.401B 22.06
Hutchison China MediTech (HCM) China $2.728B 0.00
Quidel (QDEL) United States $2.681B 26.62
Agios Pharmaceuticals (AGIO) United States $2.216B 0.00
National Vision Holdings (EYE) United States $2.181B 47.07
Cardiovascular Systems (CSII) United States $1.821B 0.00
Aphria (APHA) $1.659B 0.00
AtriCure (ATRC) United States $0.998B 0.00
Lantheus Holdings (LNTH) United States $0.977B 25.69
Omeros (OMER) United States $0.949B 0.00
Phibro Animal Health (PAHC) United States $0.894B 14.54
Eagle Pharmaceuticals (EGRX) United States $0.803B 20.47
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.763B 18.03
Cerus (CERS) United States $0.755B 0.00
LeMaitre Vascular (LMAT) United States $0.702B 41.63
MacroGenics (MGNX) United States $0.652B 0.00
Surmodics (SRDX) United States $0.640B 121.56
Quanterix (QTRX) United States $0.638B 0.00
TG Therapeutics (TGTX) United States $0.624B 0.00
OraSure Technologies (OSUR) United States $0.469B 21.71
Meridian Bioscience (VIVO) United States $0.427B 13.32
BioLife Solutions (BLFS) United States $0.392B 128.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.391B 0.00
Owens & Minor (OMI) United States $0.378B 11.32
Utah Medical Products (UTMD) United States $0.370B 27.14
United Health Products (UEEC) United States $0.330B 0.00
Zynex (ZYXI) United States $0.290B 30.83
Bovie Medical (APYX) United States $0.243B 0.00
Rockwell Medical (RMTI) United States $0.204B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.150B 10.69
Chimerix (CMRX) United States $0.141B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.087B 20.54
MRI Interventions (MRIC) United States $0.067B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
Nephros (NEPH) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00